Insider filings this week reveal a split signal from corporate suites — heavy selling at the top, but at least one prominent CEO is betting big with his own cash.
The biggest dump came from ILMN. Board member Keith Meister unloaded $148M worth of Illumina shares across 14 trades between August 4–5, filing the transactions on August 6. At roughly $200 per share, the pace was relentless. Meister sits on the board through his asset management firm — that level of selling in two days is hard to ignore.
SCHW founder Charles Schwab filed five sales totalling $34.9M over the past two weeks, trimming his stake at around $105–106 per share. The steady cadence suggests a planned disposal programme rather than panic, but the scale stands out.
At JNJ, CEO Joaquin Duato filed the sale of $10.8M in shares on August 7. CAKE founder and Chairman David Overton similarly filed a $10M exit on August 6.
The lone bullish standout: BSX CEO Michael Mahoney bought of Boston Scientific shares on August 3, paying roughly $48 each. CEOs rarely spend $9M of their own money without conviction. founder Andrew Florance also filed a $2.5M purchase in CoStar Group.
Two PFE directors separately bought nearly $1M each in Pfizer stock on August 5 — a coordinated signal worth watching at a beaten-down price of $25.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
